Revelation Biosciences Has Priced The Public Offering Of 1.365M Together With Warrants To Purchase Up To 2.730M At $4.53 Per Share And Associated Warrant, With Gross Proceeds Of $6.2M
Portfolio Pulse from Benzinga Newsdesk
Revelation Biosciences has announced the pricing of its public offering at $4.53 per share, including 1.365 million shares and warrants to purchase up to 2.730 million shares, aiming for gross proceeds of $6.2 million.
February 01, 2024 | 11:07 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Revelation Biosciences prices its public offering at $4.53 per share, including shares and warrants, with a target of $6.2 million in gross proceeds.
The pricing of the public offering and the issuance of warrants could potentially dilute existing shares but also provides the company with necessary capital. The impact on the stock price could be neutral in the short term as the benefits of capital infusion might offset the dilutive effects.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100